Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Stanford University · NCT00349830

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
2000
US sites recruiting
1
Study start
January 2002
Record last updated
February 10, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Being studied: blood draw

Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma); Neoplasms

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria
  • Age > or = 18; for the samples collected under the NIH grant, no subjects below the age of 20 will be enrolled.
  • Prior diagnosis of cancer or suspected of having cancer
  • Karnofsky performance status of greater than 70
  • Standard pretreatment evaluation
  • Signed Stanford University Human Subjects Committee consent

Recruiting US locations

  • Stanford University School of Medicine

    Stanford, CA 94305

    Site contact: Rene Bonilla · 650-498-7703 · rbonilla@stanford.edu

Study contacts (from the official record)

  • gitrialeligibility@stanford.edu gitrialeligibility@stanford.edu · 650-498-7757 · gitrialeligibility@stanford.edu
  • gitrialeligibility@stanford.edu · 650-498-7757 · gitrialeligibility@stanford.edu
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy (NCT00349830) | Bored Studies